Next step in National Medicare Coverage of DBS for treatment of
Parkinson's
- Meeting of Executive Committee of the
Medicare Coverage Advisory Committee-- September 25th announced in the
Federal Register.
For background information on this issue and the process of Medicare
coveraage decisions, see www.grassrootsconnection.com
Linda
FROM:
[Federal Register: August 23, 2002 (Volume 67, Number 164)]
pagee 54659-54660]
From the Federal Register Online via GPO Access
[wais.access.gpo.gov]
[DOCID:fr23au02-57]
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting of the Executive
Committee (the Committee) of the Medicare Coverage Advisory Committee
(MCAC). The Committee provides advice and recommendations to us about
clinical issues. The Committee will act upon recommendations from the
Medical and Surgical Procedures Panel of the MCAC regarding the use of
deep brain stimulation for the treatment of Parkinson's disease. The
Committee will also discuss approaches to assessing clinical evidence
in diagnosis and treatment of rare diseases.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)).
DATES: The Meeting: September 25, 2002 from 8 a.m. until 4:30 p.m.,
E.D.T.
Deadline for Presentations and Comments: September 12, 2002, 5
p.m., E.D.T.
Special Accommodations: Persons attending the meeting who are
hearing or visually impaired, or have a condition that requires special
assistance or accommodations, are asked to notify the Executive
Secretary by September 4, 2002 (see For Further Information Contact).
ADDRESSES:
The Meeting: The meeting will be held at the Baltimore Convention
Center, Room 321-322, One West Pratt Street, Baltimore, MD 21201.
Presentations and Comments: Submit formal presentations and written
comments to Janet A. Anderson, Executive Secretary; Office of Clinical
Standards and Quality; Centers for Medicare & Medicaid Services; 7500
Security Boulevard; Mail Stop C1-09-06; Baltimore, MD 21244.
Website: You may access up-to-date information on this meeting at
http://www.cms.gov/coverage.
Hotline: You may access up-to-date information on this meeting on
the CMS Advisory Committee Information Hotline, 1-877-449-5659 (toll
free) or in the Baltimore area (410) 786-9379.
FOR FURTHER INFORMATION CONTACT: Janet A. Anderson, Executive
Secretary, 410-786-2700.
SUPPLEMENTARY INFORMATION:
Current Panel Members
Harold C. Sox, M.D.; Daisy Alford-Smith, Ph.D.; Wade Aubry, M.D.;
Linda Bergthold, Ph.D.; Ronald M. Davis, M.D.; John H. Ferguson, M.D.;
Leslie P. Francis, J.D., Ph.D.; Alan M. Garber, M.D., Ph.D.; Thomas V.
Holohan, M.D., M.A.; Michael D. Maves, M.D., M.B.A.; Barbara J. McNeil,
M.D., Ph.D.; Robert L. Murray, Ph.D.; Frank J. Papatheofanis, M.D.,
Ph.D.; Randel E. Richner, M.P.H.
Meeting Topic
The Committee will act on recommendations from the Medical and
Surgical Procedures Panel of the MCAC regarding the use of deep brain
stimulation for treatment of Parkinson's disease. The Committee will
also discuss methods for assessing clinical evidence concerning
diagnosis and treatment of diseases that affect a small population of
patients.
Procedure and Agenda
This meeting is open to the public. The Committee will hear oral
presentations from the public for approximately 90 minutes. The
Committee may limit the number and duration of oral presentations to
the time available. If you wish to make a formal presentation, you must
notify the Executive Secretary named in the For Further Information
Contact section of this notice, and submit the following by the
Deadline for Presentations and Comments date listed in the Dates
section of this notice: A brief statement of the general nature of the
evidence or arguments you wish to present, and the names and addresses
of proposed participants. A written copy of your presentation must be
provided to the Executive Secretary before offering your public
comments. We will request that you declare at the meeting whether or
not you have any financial involvement with manufacturers of any items
or services being discussed (or with their competitors).
After the public and CMS presentations, the Committee will
deliberate openly on the topic. Interested persons may observe the
deliberations, but the Committee will not hear further comments during
this time except at the request of the chairperson. The Committee will
also allow approximately a 30-minute open public session for any
attendee to address issues specific to the topic. At the conclusion of
the day, the members will vote, and the Committee will make its
recommendation.
MCAC Executive Committee
63.240.208.147
Centers for Medicare & Medicaid Services
7500 Security Boulevard, Baltimore MD 21244-1850
Phone: 410-786-3000
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
